Page last updated: 2024-09-05

esketamine and Cognitive Dysfunction

esketamine has been researched along with Cognitive Dysfunction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Gao, JG; Li, Y; Song, RX; Wang, JX; Wu, ZY; Zheng, WC1
Li, Y; Liu, JZ; Lv, JM; Miao, HT; Shan, YD; Song, RX; Wang, LY; Wu, ZY; Zhang, DX; Zhang, LM; Zhang, W1
Hashimoto, K1
Cohen, D; Curiale, V; Jacquet, B; Laurent, I; Louchart De La Chapelle, S; Romani, S1

Reviews

1 review(s) available for esketamine and Cognitive Dysfunction

ArticleYear
Arketamine for cognitive impairment in psychiatric disorders.
    European archives of psychiatry and clinical neuroscience, 2023, Volume: 273, Issue:7

    Topics: Animals; Antidepressive Agents; Cognitive Dysfunction; Depressive Disorder, Major; Ketamine; Mice

2023

Other Studies

3 other study(ies) available for esketamine and Cognitive Dysfunction

ArticleYear
Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/ TANK-binding kinase 1 signaling pathway in aged rats.
    Brain research bulletin, 2022, Volume: 187

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cognitive Dysfunction; Hippocampus; Interferons; Ketamine; Lipopolysaccharides; Membrane Proteins; Postoperative Cognitive Complications; Postoperative Complications; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction

2022
Subanesthetic dose of S-ketamine improved cognitive dysfunction via the inhibition of hippocampal astrocytosis in a mouse model of post-stroke chronic stress.
    Journal of psychiatric research, 2023, Volume: 158

    Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Gliosis; Hippocampus; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Stroke

2023
Esketamine for resistant depression in older people with cognitive impairment: A case report.
    L'Encephale, 2023, Volume: 49, Issue:6

    Topics: Aged; Antidepressive Agents; Cognitive Dysfunction; Depression; Depressive Disorder, Treatment-Resistant; Humans; Ketamine

2023